Advertisement

Acta Neuropathologica

, Volume 138, Issue 6, pp 1091–1092 | Cite as

A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration

  • Jason Chiang
  • Julie H. Harreld
  • Christopher L. Tinkle
  • Daniel C. Moreira
  • Xiaoyu Li
  • Sahaja Acharya
  • Ibrahim Qaddoumi
  • David W. EllisonEmail author
Correspondence

Molecular alterations are increasingly being used to distinguish tumors with similar histopathologic features but distinct clinical characteristics. Among IDH-wildtype and H3-wildtype (IDH-wt/H3-wt) diffuse gliomas is an important, though uncommon, group of tumors presenting in children and young adults. These demonstrate an indolent clinical behavior, unlike IDH-mutant diffuse gliomas and the IDH-wt/H3-wt diffuse gliomas of later life [2, 3]. This group of ‘pediatric-type’ diffuse gliomas has a relatively restricted range of genetic alterations, which are distinct from those in ‘adult-type’ IDH-wt/H3-wt diffuse gliomas and involve FGFR1, BRAF, MYB and MYBL1 [2, 4]. Following the 2016 update to the World Health Organization (WHO) classification of CNS tumors, entities delineated by combinations of histopathologic and genetic characteristics and with distinctive clinical profiles have been presented in a series of papers from the cIMPACT-NOW group. These new entities include the...

Notes

Supplementary material

401_2019_2081_MOESM1_ESM.pdf (30 kb)
Supplementary file1 (PDF 29 kb)
401_2019_2081_MOESM2_ESM.tif (39.4 mb)
Supplementary file1 (TIF 40352 kb)
401_2019_2081_MOESM3_ESM.tif (35 mb)
Supplementary file1 (TIF 35850 kb)
401_2019_2081_MOESM4_ESM.tif (37.9 mb)
Supplementary file1 (TIF 38789 kb)

References

  1. 1.
    Blumcke I, Luyken C, Urbach H, Schramm J, Wiestler OD (2004) An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis. Acta Neuropathol 107:381–388.  https://doi.org/10.1007/s00401-004-0833-3 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498.  https://doi.org/10.1056/NEJMoa1402121 CrossRefGoogle Scholar
  3. 3.
    Ellison DW, Hawkins C, Jones DTW, Onar-Thomas A, Pfister SM, Reifenberger G et al (2019) cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF(V600E) mutation. Acta Neuropathol 137:683–687.  https://doi.org/10.1007/s00401-019-01987-0 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD et al (2016) Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 131:833–845.  https://doi.org/10.1007/s00401-016-1539-z CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Jason Chiang
    • 1
  • Julie H. Harreld
    • 2
  • Christopher L. Tinkle
    • 3
  • Daniel C. Moreira
    • 4
  • Xiaoyu Li
    • 1
  • Sahaja Acharya
    • 3
  • Ibrahim Qaddoumi
    • 4
  • David W. Ellison
    • 1
    Email author
  1. 1.Department of PathologySt. Jude Children’s Research HospitalMemphisUSA
  2. 2.Department of Diagnostic ImagingSt. Jude Children’s Research HospitalMemphisUSA
  3. 3.Department of Radiation OncologySt. Jude Children’s Research HospitalMemphisUSA
  4. 4.Department of OncologySt. Jude Children’s Research HospitalMemphisUSA

Personalised recommendations